{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T17:26:47Z","timestamp":1770744407462,"version":"3.49.0"},"reference-count":10,"publisher":"American Society of Hematology","issue":"21","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2019,11,21]]},"DOI":"10.1182\/blood.2019003046","type":"journal-article","created":{"date-parts":[[2019,11,21]],"date-time":"2019-11-21T12:08:44Z","timestamp":1574338124000},"page":"1777-1778","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":3,"title":["B-cell prolymphocytic leukemia has 3 subsets"],"prefix":"10.1182","volume":"134","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5951-5055","authenticated-orcid":false,"given":"Neil E.","family":"Kay","sequence":"first","affiliation":[{"name":"Mayo Clinic College of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Curtis A.","family":"Hanson","sequence":"additional","affiliation":[{"name":"Mayo Clinic College of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"234","published-online":{"date-parts":[[2019,9,16]]},"reference":[{"issue":"21","key":"2019112112083649200_B1","first-page":"1821","article-title":"Genetic characterization of B-cell prolymphocytic leukemia: a prognostic model involving MYC and TP53","volume":"134","author":"Chapiro","year":"2019","journal-title":"Blood"},{"issue":"1","key":"2019112112083649200_B2","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1111\/j.1365-2141.1974.tb06769.x","article-title":"Prolymphocytic leukaemia","volume":"27","author":"Galton","year":"1974","journal-title":"Br J Haematol"},{"issue":"4","key":"2019112112083649200_B3","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1007\/s11912-017-0581-x","article-title":"Prolymphocytic leukemia: new insights in diagnosis and in treatment","volume":"19","author":"Collignon","year":"2017","journal-title":"Curr Oncol Rep"},{"issue":"20","key":"2019112112083649200_B4","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.1182\/blood-2016-01-643569","article-title":"The 2016 revision of the World Health Organization classification of lymphoid neoplasms","volume":"127","author":"Swerdlow","year":"2016","journal-title":"Blood"},{"issue":"3","key":"2019112112083649200_B5","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1182\/blood-2013-10-533869","article-title":"B-cell prolymphocytic leukemia: a specific subgroup of mantle cell lymphoma","volume":"124","author":"van der Velden","year":"2014","journal-title":"Blood"},{"issue":"10","key":"2019112112083649200_B6","first-page":"1640","article-title":"The immunological profile of B-cell disorders and proposal of a scoring system for the diagnosis of CLL","volume":"8","author":"Matutes","year":"1994","journal-title":"Leukemia"},{"issue":"7","key":"2019112112083649200_B7","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1038\/sj.leu.2404238","article-title":"IgVH genes mutation and usage, ZAP-70 and CD38 expression provide new insights on B-cell prolymphocytic leukemia (B-PLL)","volume":"20","author":"Del Giudice","year":"2006","journal-title":"Leukemia"},{"issue":"6","key":"2019112112083649200_B8","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.1182\/blood.V89.6.2015","article-title":"p53 abnormalities in B-cell prolymphocytic leukemia","volume":"89","author":"Lens","year":"1997","journal-title":"Blood"},{"issue":"3","key":"2019112112083649200_B9","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1309\/AJCPUBHM8U7ZFLOB","article-title":"Aberrations of MYC are a common event in B-cell prolymphocytic leukemia","volume":"142","author":"Flatley","year":"2014","journal-title":"Am J Clin Pathol"},{"issue":"3","key":"2019112112083649200_B10","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1111\/bjh.14224","article-title":"Ibrutinib is an effective treatment for B-cell prolymphocytic leukaemia","volume":"179","author":"Gordon","year":"2017","journal-title":"Br J Haematol"}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/134\/21\/1777\/1541376\/bloodbld2019003046c.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/134\/21\/1777\/1541376\/bloodbld2019003046c.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,11,21]],"date-time":"2019-11-21T12:08:48Z","timestamp":1574338128000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/134\/21\/1777\/428779\/Bcell-prolymphocytic-leukemia-has-3-subsets"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9,16]]},"references-count":10,"journal-issue":{"issue":"21","published-online":{"date-parts":[[2019,9,16]]},"published-print":{"date-parts":[[2019,11,21]]}},"URL":"https:\/\/doi.org\/10.1182\/blood.2019003046","relation":{},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,9,16]]}}}